Read twice and referred to the Committee on Finance.
Email me when S 5496 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track S 5496. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill creates new limits on what people pay for prescription drugs, especially insulin, and forces insurers and providers to publish clear price information. It also raises federal aid to states during high‑unemployment periods, rescinds some previously allocated funds, and sets up a federal drug‑price negotiation program. The changes apply to Medicare, Medicaid, group health plans, hospitals, labs, imaging centers and ambulatory surgical centers.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about S 5496
3 free questions a day, no accountSponsors
- Sen. Warner, Mark R. [D-VA] (D) · sponsor
Similar bills in other states
Loading the map of where bills like this one were filed.
Topics
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when S 5496 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track S 5496 freeOr ask your AI assistant about S 5496 directly:
Add to Claude, ChatGPT or Cursor